Skip to content

CVB Financial

US · CVBF #2297 by market cap Listed 1970
21.51 -0.08 -0.37%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 16 in the most recent period (2026/Q3).
  • Total institutional ownership rose 4.7 percentage points.

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
88.07% +4.68pp
Institutions
394 +16
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund75.64%
Hedge Fund6.54%
Individual/Insider5.25%
Public Company3.75%
Government Pension Fund1.14%
Insurance Company0.56%
Private Company0.25%
Family Office/Trust0.15%
Other6.69%

Top holders as of 2026-09-30

BlackRock 14.65% · 25.57M sh
Dimensional Fund Advisors 5.81% · 10.15M sh
Vanguard Portfolio Management, LLC 5.80% · 10.12M sh
State Street Global Advisors 5.70% · 9.94M sh
FMR 4.62% · 8.06M sh
George Borba 4.49% · 7.83M sh
Vanguard Capital Management, LLC 4.33% · 7.55M sh
Charles Schwab Investment Management 3.66% · 6.38M sh
Geode Capital Management, LLC 2.58% · 4.50M sh
Parallel Advisors, LLC 2.00% · 3.50M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 23 buys · 26 sells

NameRoleStake
George Borba Independent Chairperson 4.49%
Robertson Jones President 0.15%
David Brager Chief Executive Officer 0.14%
E. Nicholson Chief Financial Officer 0.08%
Yamynn DeAngelis Former Executive Vice President 0.07%
David Harvey Chief Operating Officer 0.06%
Raymond O’Brien Independent Director 0.05%
David Farnsworth Chief Credit Officer 0.05%
Hal Oswalt Independent Vice Chairperson 0.03%
Stephen Del Guercio Independent Director 0.03%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-10-19 Sheryl Laygo Chief Accounting Officer Sale to Issuer -359 $22.16
2026-08-30 Michael Maddox Director Open Market Acquisition +10,000 $22.03
2026-08-22 Michael Maddox Director Other Acquisition +3,138 $22.57
2026-08-04 David Harvey Chief Operating Officer Open Market Disposition -40,000 $22.94
2026-08-03 David Harvey Chief Operating Officer Intent to Sell (Form 144) -40,000 $23.19
2026-07-27 Raymond O’Brien Independent Director Open Market Acquisition +20,000 $22.77
2026-07-21 Michael Maddox Director Initial Statement of Beneficial 0 --
2026-06-04 Richard Wohl Former Executive Vice President Sale to Issuer -8,944 $20.50
2026-05-31 Yamynn DeAngelis Former Executive Vice President Sale to Issuer -11,109 $20.10
2026-05-21 George Borba Independent Chairperson Open Market Acquisition +48,894 $20.45
2026-05-19 Julianne Biagini-Komas Director Other Acquisition +4,187 --
2026-05-19 Raymond O’Brien Independent Director Other Acquisition +4,187 --
2026-05-19 Hal Oswalt Independent Vice Chairperson Other Acquisition +4,187 --
2026-05-19 George Borba Independent Chairperson Other Acquisition +4,187 --
2026-05-19 Stephen Del Guercio Independent Director Other Acquisition +4,187 --
2026-05-19 Anna Kan Independent Director Other Acquisition +4,187 --
2026-05-19 Jane Majors Independent Director Other Acquisition +4,187 --
2026-05-19 Timothy Stephens Independent Director Other Acquisition +4,187 --
2026-05-18 George Borba Independent Chairperson Open Market Acquisition +25,187 $19.85
2026-05-13 George Borba Independent Chairperson Open Market Acquisition +25,097 $19.92

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

CVB Financial discussion 0 comments

Add a comment